- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01552135
Pilot Study - Putative Penetration of Nanoparticles in Sunscreen in Intact or Sunburned Skin
March 6, 2020 updated by: Bato Hammarstrøm, Oslo University Hospital
Pilot Study - Does Nanoparticles in Sunscreen Penetrate Intact or Sunburned Skin?
The investigators want to study if nanoparticles of titaniumdioxide are penetrating skin when the skin is intact and when the skin is sunburned.
The hypothesis is "Does nanotitandioxide penetrate intact or sunburned skin?"
Study Overview
Status
Completed
Detailed Description
In this pilotstudy there are two human volunteers.
The study comprises two phases.
The first phase: The volunteers are applying a commercially available sunscreen lotion containing titanium dioxide nano particles 6 times a day for one week in an area of the back that is 30x20 cm.
Before the first application a 2mm punch biopsy is to be taken and examined by scanning electron microscopy.
After applying sunscreen lotion for a week, a new biopsy will be taken in order to see how far down in the skin the particles have penetrated.
In the second phase: An artificial sunburn will be induced in the same area of the back.
They will thereafter apply the sunscreen lotion 6 times a day like in the first phase.
After two days (estimated time of maximum skin irritation) a biopsy will be taken in order to see if the nanoparticles have penetrated down in the layers of the skin, and the investigators will also take a biopsy after a full week of applying the sunscreen lotion.
The investigators will also examine the urine, before and after the use of sunscreen, to see if the investigators can find the particles there.
Study Type
Observational
Enrollment (Actual)
2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Oslo, Norway, 4956
- Oslo University Hospital, Dept. of Environmental and Occupational Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Sampling Method
Non-Probability Sample
Study Population
2 healthy males older than 50 years
Description
Inclusion Criteria:
- Healthy men above 50 years old
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Healthy
Healthy men above 50 years old
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Depth of penetration of nano particles in skin
Time Frame: One Week
|
One Week
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Occurrence of nano particles in urine
Time Frame: Two weeks
|
Two weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Marit Gulbrandsen, MD, University Hospital of North Norway
- Principal Investigator: Jan-Oivind Holm, MD PhD, Oslo University Hospital
- Principal Investigator: Vidar Skaug, MD, National Institute of Occupational Health, Norway
- Study Director: Elise Naess, MD, Oslo University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2012
Primary Completion (Actual)
May 1, 2012
Study Completion (Actual)
June 1, 2014
Study Registration Dates
First Submitted
March 1, 2012
First Submitted That Met QC Criteria
March 8, 2012
First Posted (Estimate)
March 13, 2012
Study Record Updates
Last Update Posted (Actual)
March 10, 2020
Last Update Submitted That Met QC Criteria
March 6, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2011/2567B
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Skin
-
Biocoz Global Pte. Ltd.Not yet recruitingHealthy Skin | Skin HydrationUnited States
-
University of California, San DiegoCompleted
-
Rao DermatologyRecruitingHealthy SkinUnited States
-
Amazentis SARecruitingHealthy | Healthy Aging | Healthy DietUnited States
-
Amazentis SASGS proderm GmbHCompleted
-
Amazentis SASGS proderm GmbHCompleted
-
First Hospital of China Medical UniversityNot yet recruiting
-
University of California, San DiegoWithdrawnFocus: Healthy Skin MicrobiomeUnited States
-
AllerganCompletedHealthy Adults | Skin EnhancementPoland